Improving Patient Care with CT-based Commercial Software Applications

COPD is heterogeneous in its clinical manifestations and disease progression. Patients often have disease courses that are difficult to predict with readily available data, such as lung function testing.

The ability to better classify COPD into well-defined groups will allow researchers and clinicians to tailor novel therapies and improve patient-centered outcomes. Different modalities of assessing these COPD phenotypes are actively being studied, and an area of great promise includes the use of quantitative computed tomography (QCT) techniques focused on key features such as airway anatomy, lung density, and vascular morphology. Over the last few decades, companies around the world have commercialized automated CT software packages that have proven immensely useful in these endeavors.

Recently, an article was published that reviewed the key features of several commercial platforms, including the technologies they are based on, the metrics they can generate, and their clinical correlations and applications. One of these platforms is Functional Respiratory Imaging (FRI), developed by Fluidda N.V.

You can read the full article HERE.

Categorised in: Miscellaneous / April 5, 2023 1:00 pm / Published by Fluidda